We are live on ! Find out more
IRTC icon

iRhythm Holdings

127.80 USD
+3.81
3.07%
At close Updated Oct 29, 4:00 PM EDT
Pre-market
After hours
127.80
0.00
0%
1 day
3.07%
5 days
7.08%
1 month
11.89%
3 months
4.38%
6 months
5.84%
Year to date
-27.06%
1 year
-31.03%
5 years
82.21%
10 years
412.22%
 

About: iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Employees: 2,400

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 40.9%
Neutral 59.1%
Negative 0%
Neutral
Zacks Investment Research
18 hours ago
iRhythm Holdings, Inc. (IRTC) Earnings Expected to Grow: Should You Buy?
IRHYTHM HLDGS (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
iRhythm Holdings, Inc. (IRTC) Earnings Expected to Grow: Should You Buy?
Neutral
GlobeNewsWire
14 days ago
iRhythm Holdings to Report Third Quarter 2026 Financial Results on November 5, 2026
SAN FRANCISCO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it will release financial results for the third quarter 2026 after the close of trading on Thursday, November 5, 2026. The company's management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.
iRhythm Holdings to Report Third Quarter 2026 Financial Results on November 5, 2026
Neutral
PRNewsWire
16 days ago
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Neutral
GlobeNewsWire
23 days ago
iRhythm Holdings Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Patient Data Is Exposed
Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from a reported data breach at iRhythm Holdings, Inc.
iRhythm Holdings Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Patient Data Is Exposed
Neutral
GlobeNewsWire
24 days ago
iRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care
SAN FRANCISCO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (Nasdaq: IRTC) today announced that it completed the previously announced acquisition of Vital Connect, Inc. ("VitalConnect"), a leader in wearable biosensor technology and ambulatory cardiac monitoring.
iRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care
Neutral
GlobeNewsWire
27 days ago
iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026
Following completion of the forensic investigation, company begins notifying impacted individuals Following completion of the forensic investigation, company begins notifying impacted individuals
iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026
Neutral
GlobeNewsWire
1 month ago
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
NEW YORK, Sept. 27, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of  iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders.
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
Positive
Zacks Investment Research
1 month ago
Here's Why You Should Retain IRTC Stock in Your Portfolio for Now
iRhythm's Q2 momentum, AI-driven predictive care and deeper EHR integration support growth, though reimbursement pressures remain.
Here's Why You Should Retain IRTC Stock in Your Portfolio for Now
Positive
Zacks Investment Research
1 month ago
Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated?
iRhythm's Q2 revenue growth, margin expansion and record free cash flow strengthen its case, but reimbursement and regulatory risks remain elevated.
Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated?
Neutral
GlobeNewsWire
2 months ago
iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference
SAN FRANCISCO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it will participate in the upcoming Wells Fargo 21st Annual Healthcare Conference.
iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference
Price charts implemented using Lightweight Charts™